Literature DB >> 3264191

Interleukin-3 and interleukin-1 alpha allow earlier bone marrow progenitors to respond to human colony-stimulating factor 1.

Y Q Zhou1, E R Stanley, S C Clark, J A Hatzfeld, J P Levesque, C Federici, S M Watt, A Hatzfeld.   

Abstract

By using human bone marrow cells enriched for early progenitors by selective immunoadsorption and plated at low cell density (10(3) to 10(4) cells/mL/9.6 cm2) in semisolid methylcellulose culture, we have analyzed the cooperative effects of human colony-stimulating factor 1 (CSF-1), granulocyte-macrophage-CSF (GM-CSF), interleukin-1 alpha (IL-1 alpha), and gibbon as well as human recombinant IL-3 on the formation of monocytic colonies. CSF-1 alone stimulated mature monocytic colony formation by human CFU-M. However, in the presence of IL-3 and erythropoietin, CSF-1 stimulated maximal immature monocytic colony formation at low concentrations and inhibited the formation of granulomonocytic, erythrocytic, and mixed colonies. Cultures with CSF-1 and IL-3 contained more immature monocytic colonies than did cultures with CSF-1 alone. IL-1 alpha alone had little effect. However, IL-1 alpha in combination with optimal concentrations of either CSF-1, GM-CSF, or IL-3 increased the number of colonies containing immature or mature monocytic colonies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264191

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  In vivo IL-1 potentiates both specific and non-specific arms of immune response to infection.

Authors:  C Cheers; Y F Zhan; P J Egan
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

2.  Comparative analysis of the influences of IL-1, IL-3 and GM-CSF on the commitment of granulocyte-macrophage progenitors in vitro.

Authors:  J Maciejewski; H Weber; K Neuhaus; M Wächter; E Elstner; F R Seiler; H D Volk
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

3.  IL-1 beta and IL-3-like activity in preterm infants.

Authors:  H Bessler; L Sirota; I Notti; F Dulitzky; M Djaldetti
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

4.  Cryopreservative effect of leupeptin on early human bone marrow progenitors.

Authors:  M L Li; B Panterne; J P Levesque; A Hatzfeld; J Hatzfeld
Journal:  In Vitro Cell Dev Biol       Date:  1992-06

5.  Prophylaxis or treatment of experimental brucellosis with interleukin-1.

Authors:  Y F Zhan; E R Stanley; C Cheers
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

Review 6.  Human endothelial stem/progenitor cells, angiogenic factors and vascular repair.

Authors:  Suzanne M Watt; Athanasios Athanassopoulos; Adrian L Harris; Grigorios Tsaknakis
Journal:  J R Soc Interface       Date:  2010-09-15       Impact factor: 4.118

Review 7.  Why clinicians should be interested in interleukin-3.

Authors:  P Valent; K Geissler; C Sillaber; K Lechner; P Bettelheim
Journal:  Blut       Date:  1990-12

8.  Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults.

Authors:  A A Cardoso; M L Li; P Batard; A Hatzfeld; E L Brown; J P Levesque; H Sookdeo; B Panterne; P Sansilvestri; S C Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  The in vitro response of phenotypically defined mouse stem cells and myeloerythroid progenitors to single or multiple growth factors.

Authors:  S Heimfeld; S Hudak; I Weissman; D Rennick
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

10.  Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides.

Authors:  J Hatzfeld; M L Li; E L Brown; H Sookdeo; J P Levesque; T O'Toole; C Gurney; S C Clark; A Hatzfeld
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.